Paul Wadwa, MD

For Patients:
My primary research focus is on the development of the artificial pancreas for patients with type 1 diabetes. I am involved in many clinical research studies with the goal of advancing artificial pancreas technology. I am also engaged in clinical trials of new therapeutic agents as well as research describing the effects of a clinical telemedicine program on diabetes control for youth with type 1 diabetes. My hope is that the research I am involved with will greatly improve the tools available to optimize control and reduce the burden of diabetes for patients locally and beyond.

For Referring Providers:
Dr. Wadwa’s research primarily focuses on the development of the artificial pancreas. He is engaged as a site PI and as a co-investigator for several NIH-sponsored and industry- sponsored clinical research studies with the goal of advancing artificial pancreas technology. Dr. Wadwa is also engaged in clinical trials of new therapeutic agents as well as research describing the effects of a clinical telemedicine program on glycemic control in pediatric type 1 diabetes patients.